Market Overview

Monday's #PreMarket Movers: Spectrum Pharmaceuticals, Cyberark Software Trending Down

Share:

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) -26% - Received unfavorable litigation ruling in Fusilev case.

Cyberark Software Ltd (NASDAQ: CYBR) -5% - Downgraded to Underweight at JP Morgan.

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) +45% - Reported research collaboration with Bristol-Myers Squibb.

Biocept Inc (NASDAQ: BIOC) +27% - Announced favorable findings from OncoCEE-BR Study.

Ballard Power Systems Inc. (USA) (NASDAQ: BLDP) +16% - Signed two new technology contracts.

Polypore International, Inc. (NYSE: PPO) +13% - Polypore’s media business will be acquired by 3M for $1 billion.

Celldex Therapeutics, Inc. (NASDAQ: CLDX) +14.5% - Received breakthrough designation from FDA for its Rintega therapy.

ADMA Biologics Inc (NASDAQ: ADMA) +5% - Reported positive data from phase III RI-002 trial.

Home Loan Servicing Solutions Ltd (NASDAQ: HLSS) +8% - New Residential will acquire HLSS for $18.25 per share.

Tower Semiconductor Ltd. (USA) (NASDAQ: TSEM) +8.7% - Announced Q4 EPS.

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) +9% - Announced purchase of Salix Pharmaceuticals for ~$10 billion.

Ocwen Financial Corp (NYSE: OCN) +2.6% - Announced intent to sell $9.8 billion in assets.

Pacific Drilling SA (NYSE: PACD) +4.3% - Reported Q4 EPS.

Posted-In: News Pre-Market Outlook Movers

 

Related Articles (BIOC + ADMA)

View Comments and Join the Discussion!

Barclays Upgrades Teleflex To Overweight

Bank of America Downgrades Quest Diagnostics To Underperform